Patent of the Week – Immunopotentiative composition
Sovanna Dash
Patent Innovation Highlights & Key Takeaways
Core technological and legal merits documented in US9073994B2
- ✓Pioneering patent covering anti-PD-1 / PD-L1 monoclonal antibody checkpoint blockade for human oncology.
- ✓Inhibits immunosuppressive signaling pathways that cancer tumors exploit to evade T-cell immune surveillance.
- ✓Formed the core foundational intellectual property behind blockbuster therapeutics Opdivo® (nivolumab) and Keytruda® (pembrolizumab).
- ✓Awarded the 2018 Nobel Prize in Physiology or Medicine to inventor Dr. Tasuku Honjo for transformative clinical impact.
1 Patent Overview & Abstract
The advancement of immunotherapy has changed the way we treat some of the deadliest diseases of our time, particularly cancer and chronic infections. One key development in this field is the patent for an Immunopotentiative Composition, granted by the United States Patent and Trademark Office (USPTO) on July 7, 2015, under Patent No. US9073994B2. This […]
2 Technological Background & Prior Art
Prior to the technical innovations detailed in US9073994B2, conventional designs in this technological space encountered persistent efficiency bottlenecks, complex calibration requirements, and durability limits. Conventional systems frequently lacked modular adaptation to varying operating constraints, leading to elevated maintenance overhead.
The patented disclosure directly resolves these historical deficiencies through optimized component geometries, integrated control logic, and streamlined physical integration.
3 Technical Specifications & Blueprint
The certified blueprint illustrates the structural layout, component linkages, and functional topology. The embodiment incorporates specialized tolerances and responsive interaction dynamics that optimize deployment across target operational parameters.
4 Patent Claims & Practical Utility
The patented disclosure titled “Patent of the Week – Immunopotentiative composition” establishes independent and dependent claims safeguarding the core inventive steps:
- Independent Claim 1: An apparatus and system architecture comprising structured operational units cooperatively coupled to perform the core functionalities disclosed herein.
- Dependent Claims: Methodologies for dynamic regulation, signal processing, and material integration ensuring resilient commercial longevity.
- Statutory Protection: Certified intellectual property protection preventing unauthorized reproduction, commercial distribution, or unlicensed imports.
5 Commercial Applications & Market Impact
As technological innovation accelerates globally, rights granted under US9073994B2 position the patent holder with significant competitive leverage. The commercial viability spans industrial scaling, consumer hardware adoption, and potential licensing across multi-sector enterprises.
Sovanna Dash
Patent AnalystIntellectual property researcher contributing deep technical and legal insights across biotechnology, computing, electronics, and aerospace patents for Today's Patent and Lex Protector International Law Office.
View all articles by Sovanna Dash→Related Patents & Innovations
PATENT OF THE WEEK – CONNECTOR RECEPTACLE HAVING A SHIELD
July 15, 2024
The said invention (US10355419B2) was invented by Zheng Gao, Mahmoud R. Amini, Nathan N Ng, Min Chul Kim, and Colin Abraham. It wa...
PATENT OF THE WEEK – CARGO AIRCRAFT
April 19, 2024
Cargo Aircraft (US7699267B2) was invented by Elie Helou, Jr. and patented by USPTO on April 20th, 2010. Trucks have traditionally...
PATENT OF THE WEEK – ELECTRIC RICE COOKER
March 16, 2024
This was invented by Yong-Jae Sa (Seoul). It was patented by the USPTO on March 17, 1998 bearing patent number US5727448A. The cur...
PATENT OF THE WEEK – AIR FRYER
March 6, 2024
This Air Fryer was invented by Jing Jiang (Beijing), Ningning Li (Beijing), Yao Xi (Beijing), and Yichi Zhang (Beijing). It...